Clinical trial
Conditioning Regimen in Nonmyeloablative Allogeneic Hematopoietic Stem Cell…
NCT00429026 · M.D. Anderson Cancer Center, Other · Terminated
Key facts
| NCT number | NCT00429026 |
|---|---|
| Title | Conditioning Regimen in Nonmyeloablative Allogeneic Hematopoietic Stem Cell Transplantation |
| Official title | Adaptive Randomization of Fludarabine-Melphalan Versus Fludarabine-Cyclophosphamide Conditioning Regimen in Nonmyeloablative Allogeneic Hematopoietic Stem Cell Transplantation Using HLA-Matched Related Donor for Metastatic Renal Cell Carcinoma |
| Lead sponsor | M.D. Anderson Cancer Center, Other |
| Status | Terminated |
| Phase | Phase 2 |
| Study type | Interventional |
| Conditions | Renal Cell Cancer |
| Intervention type | Drug, Procedure |
| Interventions | Fludarabine, Melphalan, Cyclophosphamide, Stem Cell Transplant |
| Enrollment | 40 |
| Start date | Jan 1, 2004 |
| Primary completion | Mar 1, 2008 |
| Completion | Mar 1, 2008 |
| First posted | Jan 31, 2007 |
| Last update posted | Mar 4, 2013 |
| Countries | United States |
At a glance
- 1–9 Study sites
- Yes Results posted
- None Linked FDA submissions
Counts are shown as ranges. Exact figures, trends and every underlying record are available in Orca1.
About ClinicalTrials.gov studies
ClinicalTrials.gov is the U.S. National Library of Medicine's registry of clinical studies conducted around the world. Contact and investigator details are not shown here.
Source: U.S. National Library of Medicine (NLM), ClinicalTrials.gov · Source date: